Cosmos Holdings, Inc. Acquires Decahedron Ltd.
(firmenpresse) - CHICAGO, IL -- (Marketwired) -- 02/14/17 -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that the Company acquired 100% of the shares of Decahedron Ltd, a privately held company located in Harlow, United Kingdom just north of London.
Decahedron Ltd. is a pharmaceutical wholesaler incorporated in the UK in August 2011 and it is audited by the MHRA (Medicines and Healthcare Products Regulatory Agency) under European GDP (Good Distribution Practices). Decahedron is also a full member of the EAEPC (European Association of Euro-Pharmaceutical Companies) and has been audited by TÜV on behalf of EAEPC. Decahedron Ltd. has established very good business relationships and maintains an outstanding reputation within the UK market with both suppliers and customers. The company imports and exports branded, generic and unlicensed medicines, OTCs and Medical devices in many countries. Also, it participates in governmental tenders and registering. Its network consists of more than 25 clients and vendors expanding to nine countries including: Germany, UK, Denmark, United Arab Emirates, Germany, Italy, France, Singapore, and Ireland.
Cosmos Holdings CEO Gregory Siokas commented, "Decahedron is a great addition to Cosmos Holding''s pharmaceutical trade business. Through this acquisition we expect to have a greater access to the UK pharmaceutical inventories and expand our sourcing and selling network both within and beyond Europe. We look forward to working with the team at Decahedron."
Cosmos Holdings Inc. is a pharmaceutical company focused on identifying, acquiring, developing, and commercializing medicines to improve patients'' lives and outcomes. The Company has a trans-European network of more than 60 clients and vendors in Germany, the United Kingdom, Ireland, Denmark, Poland, Netherlands, and Greece. Its warehouse and distribution center is located in Thessaloniki, Greece and is GDP & ISO 9001:2008 certified. More information is available at .
Cosmos Holdings, Inc. takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.
Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company''s actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company''s filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.
For More Information, Contact:
Steve Carr
Managing Director, Dresner Corporate Services
(312) 780-7211
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.02.2017 - 10:06 Uhr
Sprache: Deutsch
News-ID 1486662
Anzahl Zeichen: 2351
contact information:
Contact person:
Town:
CHICAGO, IL
Phone:
Kategorie:
Drugs
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 266 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cosmos Holdings, Inc. Acquires Decahedron Ltd.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Cosmos Holdings (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
